Skip to main content

Animations

MJFF Publications

7211 - 7220 of 8808 Results
Title
Year
  • Year
  • 2017
  • 2017
  • 2025
  • 2022
  • 2025
  • 2019
  • 2023
  • 2020
  • 2017
  • 2021
  • Summary Details
    RESTRICTED
    Title: Improved Neuroimaging Atlas of the Dentate Nucleus
    Journal Name: The Cerebellum
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s12311-017-0872-7
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0189161
    Citation Count: 162
  • Summary Details
    OPEN
    Title: Mapping cerebral blood perfusion and its links to multi-scale brain organization across the human lifespan
    Journal Name: PLOS Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pbio.3003277
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00397-6
    Citation Count: 59
  • Summary Details
    OPEN
    Title: Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine model
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-025-02859-6
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Generation of human midbrain organoids from induced pluripotent stem cells
    Journal Name: MNI Open Research
    Publisher: F1000 Research Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.12688/mniopenres.12816.1
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00476-2
    Citation Count: 14
  • Summary Details
    OPEN
    Title: CoolMPS: evaluation of antibody labeling based massively parallel non-coding RNA sequencing
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/nar/gkaa1122
    Citation Count: 14
  • Summary Details
    RESTRICTED
    Title: DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.11.046
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Effects of Excess Brain-Derived Human α-Synuclein on Synaptic Vesicle Trafficking
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2021.639414
    Citation Count: 15
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.